Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 6Neoplasms 3Melanoma 3Glioma 3Stomach Neoplasms 2Glioblastoma 2Breast Neoplasms 2Thyroid Diseases 1Skin Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Paget Disease, Extramammary 1Ovarian Neoplasms 1Neuroma, Acoustic 1Lung Neoplasms 1Laryngeal Neoplasms 1Irritable Bowel Syndrome 1Gastrointestinal Stromal Tumors 1Gastrointestinal Diseases 1Gastroesophageal Reflux 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Cerebrovascular Disorders 1Carcinoma, Hepatocellular 1Barrett Esophagus 1Astrocytoma 1Adenomatous Polyps 1Adenolymphoma 1

Interventions

Temozolomide 405Radiotherapy 202Bevacizumab 157Radiation 80Magnetic Resonance Spectroscopy 77Lomustine 49Surgical Procedures, Operative 45Carmustine 41pembrolizumab 40Irinotecan 38Nivolumab 32Specimen Handling 28Carboplatin 27Radiosurgery 24Erlotinib Hydrochloride 24Drug Therapy 23Chemotherapy, Adjuvant 23Radiotherapy, Intensity-Modulated 22Cyclophosphamide 20Aminolevulinic Acid 20O(6)-benzylguanine 17sargramostim 16Radiotherapy, Conformal 15Blood Specimen Collection 15temsirolimus 14Granulocyte-Macrophage Colony-Stimulating Factor 14Everolimus 14Vorinostat 13Sorafenib 13Ipilimumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioblastoma × Fluorescein × Clear all
NCT03291977 2022-11-09

FLEGME

Rennes University Hospital

Phase 3 Completed
51 enrolled
CNS

Glioblastoma

NCT02540135 2018-07-20

Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma

University of Colorado, Denver

Phase NA Withdrawn
CNS

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡